造影剤の世界市場予測（～2021年）：ヨード系造影剤、ガドリニウム造影剤、バリウム造影剤、マイクロバブル...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Insights From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Forecast Methodology
2.5 Market Data Validation and Triangulation
2.6 Assumptions

3 Executive Summary (Page No. – 28)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 32)
4.1 Contrast Media Market Overview
4.2 Contrast Media Market, By Type and Route of Administration (2016)
4.3 Geographic Snapshot: Contrast Media Market
4.4 Global Contrast Media Market, By Indication (2016 vs 2021)

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Large Number of Approvals for Contrast Agents
5.2.1.2 Increasing Number of Public and Private Diagnostic Centers
5.2.2 Restraint
5.2.2.1 Side Effects and Allergic Reactions Associated With Contrast Agents
5.2.3 Opportunity
5.2.3.1 Increasing Number of Research and Funding Activities for Contrast Agents
5.2.4 Challenges
5.2.4.1 Development of Gamma and Neutron Imaging Solutions
5.2.4.2 Need for Highly Skilled Professionals

6 Pipeline Assessment (Page No. – 44)
6.1 Introduction
6.1.1 Clinical Trials Using Contrast Media
6.1.2 Product Pipeline

7 Global Contrast Media Market, By Type (Page No. – 50)
7.1 Introduction
7.2 Iodinated Contrasts Media
7.3 Gadolinium-Based Contrasts Media
7.4 Microbubble Contrasts Media
7.5 Barium- Based Contrasts Media

8 Global Contrast Media Market, By Medical Procedure (Page No. – 57)
8.1 Introduction
8.2 X-Ray/CT
8.3 MRI
8.4 Ultrasound

9 Global Contrast Media Market, By Route of Administration (Page No. – 63)
9.1 Introduction
9.2 Injectable Contrasts Media
9.3 Oral Contrasts Media
9.4 Rectal Contrasts Media
9.5 Urethral Contrasts Media

10 Global Contrast Media Market, By Indication (Page No. – 70)
10.1 Introduction
10.2 Cardiovascular Disorders
10.3 Oncology
10.4 Gastrointestinal Disorders
10.5 Neurological Disorders
10.6 Nephrological Disorders
10.7 Musculoskeletal Disorders

11 Global Contrast Media Market, By Application (Page No. – 78)
11.1 Introduction
11.2 Radiology
11.3 Interventional Cardiology
11.4 Interventional Radiology

12 Contrast Media Market, By Region (Page No. – 83)
12.1 Introduction
12.2 North America
12.2.1 U.S.
12.2.1.1 Increasing Number of Diagnostic Imaging Tests and Centers
12.2.1.2 Rising Aging Population, Rising Prevalence of Chronic Diseases
12.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias
12.2.2 Canada
12.2.2.1 Rising Aging Population, High Incidence of Cancer, Cvd, and Diabetes
12.2.2.2 Increasing MRI and CT Examinations
12.2.2.3 Increasing Research Activities
12.3 Europe
12.3.1 Europe 5
12.3.1.1 Increase in Investments By Market Players
12.3.1.2 Increasing Incidence and Prevalence of Cancer
12.3.1.3 U.K.: Lack of Sufficient Instruments
12.3.1.4 Conferences/Meetings/Symposiums/Workshops in Europe
12.3.2 RoE
12.3.2.1 Increase Focus of Market Players on RoE Countries
12.4 Asia-Pacific
12.4.1 Rise in Aging Population and Cancer Incidence
12.4.2 Expansion of International Players in China and India
12.4.3 Increasing R&D Investments in China
12.4.4 Favorable Regulatory Changes in New Zealand and Australia
12.4.5 Increasing Research Activities in Asia-Pacific
12.5 Rest of the World
12.5.1 Latin America
12.5.2 The Middle East
12.5.3 Africa

13 Competitive Landscape (Page No. – 120)
13.1 Overview
13.2 Market Share Analysis
13.2.1 Bayer Healthcare
13.2.2 GE Healthcare
13.3 Competitive Scenario
13.3.1 Market Developments (Product Approvals)
13.3.2 Agreements, Collaborations, Contracts, and Partnerships
13.3.3 Expansions
13.3.4 Other Strategies

14 Company Profiles (Page No. – 127)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
14.1 Introduction
14.2 GE Healthcare
14.3 Bayer AG
14.4 Bracco Imaging S.P.A.
14.5 Guerbet Group
14.6 Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)
14.7 Nanopet Pharma GmbH
14.8 CMC Contrast AB
14.9 Daiichi Sankyo
14.10 Subhra Pharma Private Limited
14.11 Spago Nanomedical AB

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

15 Appendix (Page No. – 149)
15.1 Discussion Guide
15.2 Other Developments
15.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
15.4 Introducing RT: Real-Time Market Intelligence
15.5 Available Customizations
15.6 Related Reports